These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20379042)

  • 1. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugida F; Nakamura M
    Int Heart J; 2010 Mar; 51(2):98-104. PubMed ID: 20379042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Nakamura M; Okumura K
    Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profiles, efficacy of antiarrhythmic drug therapy, and cardiovascular prognosis in patients with first detected paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Satoh Y; Ozawa M; Kunugita F; Nakamura M
    Int Heart J; 2011; 52(1):32-8. PubMed ID: 21321466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
    Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast atrial activity predicts recurrence of atrial fibrillation after pulmonary vein isolation: results from a prospective randomized study.
    Kriatselis C; Kaufmann J; Nedios S; Liu J; Gerds-Li JH; Fleck E
    J Interv Card Electrophysiol; 2015 Mar; 42(2):101-6. PubMed ID: 25591723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugita F; Nakamura M
    Int Heart J; 2011; 52(6):359-65. PubMed ID: 22188709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugida F; Orii M; Nakamura M
    Int Heart J; 2009 Jul; 50(4):465-76. PubMed ID: 19609051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between CHADS2 score and efficacy of antiarrhythmic drug therapy in patients with paroxysmal atrial fibrillation.
    Komatsu T; Sato Y; Ozawa M; Kunugita F; Ueda H; Tachibana H; Morino Y; Nakamura M
    Circ J; 2013; 77(3):639-45. PubMed ID: 23220771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
    Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC;
    J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention.
    Delfaut P; Saksena S; Prakash A; Krol RB
    J Am Coll Cardiol; 1998 Dec; 32(7):1900-8. PubMed ID: 9857870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of patients with paroxysmal atrial fibrillation depends on their response to antiarrhythmic therapy.
    Komatsu T; Nakamura S; Suzuki O; Horiuchi D; Yomogida K; Okumura K
    Circ J; 2004 Aug; 68(8):729-33. PubMed ID: 15277730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
    Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
    Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
    Komatsu T; Sato Y; Tachibana H; Nakamura M; Horiuchi D; Okumura K
    Circ J; 2006 Jun; 70(6):667-72. PubMed ID: 16723785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological approaches in the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Delpón E
    Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
    Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.